Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Methotrexate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methotrexate 20mg/0.8ml inj pre-filled disposable devices
0801030P0AAFSFS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 487 |
|
Methotrexate 25mg/1ml inj pre-filled disposable devices
0801030P0AAFUFU
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 404 |
|
Methotrexate 15mg/0.6ml inj pre-filled disposable devices
0801030P0AAFQFQ
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 313 |
|
Methotrexate 25mg/1ml inj pre-filled syringes
0801030P0AAFGFG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 218 |
|
Methotrexate 20mg/0.8ml inj pre-filled syringes
0801030P0AAFEFE
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 217 |
|
Methotrexate 17.5mg/0.7ml inj pre-filled disposable devices
0801030P0AAFRFR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 143 |
|
Methotrexate 15mg/0.6ml inj pre-filled syringes
0801030P0AAFKFK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 138 |
|
Methotrexate 10mg/0.4ml inj pre-filled disposable devices
0801030P0AAFNFN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 129 |
|
Methotrexate 12.5mg/0.5ml inj pre-filled disposable devices
0801030P0AAFPFP
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 108 |
|
Methotrexate 22.5mg/0.9ml inj pre-filled disposable devices
0801030P0AAFTFT
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 83 |
|
Methotrexate 7.5mg/0.3ml inj pre-filled disposable devices
0801030P0AAFMFM
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 77 |
|
Methotrexate 10mg/0.4ml inj pre-filled syringes
0801030P0AAFHFH
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 75 |
|
Methotrexate 22.5mg/0.9ml inj pre-filled syringes
0801030P0AAFFFF
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 52 |
|
Methotrexate 7.5mg/0.3ml inj pre-filled syringes
0801030P0AAFIFI
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 51 |
|
Methotrexate 17.5mg/0.7ml inj pre-filled syringes
0801030P0AAFLFL
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 50 |
|
Methotrexate 12.5mg/0.5ml inj pre-filled syringes
0801030P0AAFJFJ
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 36 |
|
Methotrexate 5mg/2ml solution for injection vials
0801030P0AAAIAI
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 2 |
|
Methotrexate 1g/10ml solution for injection vials
0801030P0AACKCK
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 1 |
|
Methotrexate 50mg/2ml solution for injection vials
0801030P0AAANAN
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 1 |
|
Methotrexate 1g/40ml solution for injection vials
0801030P0AACTCT
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 200mg/8ml solution for injection vials
0801030P0AAASAS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 25mg/3ml inj pre-filled syringes
0801030P0AAFDFD
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 27.5mg/1.1ml inj pre-filled syringes
0801030P0AADRDR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 30mg/1.2ml inj pre-filled syringes
0801030P0AACGCG
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 32.5mg/1.3ml inj pre-filled syringes
0801030P0AAEAEA
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.